Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 109.20K | 90.40K | 22.20K | 26.00K | 19.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.20K | 90.40K | 22.20K | 26.00K | 19.30K |
| Cost of Revenue | 41.10K | 60.80K | 14.40K | 65.00K | 9.60K |
| Gross Profit | 68.20K | 29.60K | 7.80K | -39.00K | 9.60K |
| SG&A Expenses | 304.70K | 370.70K | 316.20K | 457.20K | 521.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 345.70K | 431.50K | 330.60K | 522.20K | 531.60K |
| Operating Income | -236.50K | -341.10K | -308.40K | -496.20K | -512.30K |
| Income Before Tax | 577.20K | -645.80K | 5.01M | 2.17M | 15.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 577.20K | -645.80K | 5.01M | 2.17M | 15.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 577.20K | -645.80K | 5.01M | 2.17M | 15.43M |
| EBIT | -236.50K | -341.10K | -308.40K | -496.20K | -512.30K |
| EBITDA | -230.60K | -335.20K | -303.10K | -493.30K | -509.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 7.59B | 7.47B | 7.35B | 7.33B | 7.29B |
| Average Diluted Shares Outstanding | 15.60B | 7.47B | 14.50B | 7.33B | 12.67B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |